AstraZeneca Gets Approval for Blood Pressure Drug
From Associated Press (April 12, 2012)
NEW YORK -- AstraZeneca plc said Thursday that regulators approved its blood pressure medication Dutoprol, and the British drugmaker said it plans to ship the drug directly to patients.
Dutoprol is a once-per-day treatment for hypertension. It combines the active ingredient in AstraZeneca's drug Toprol with a low-dose diuretic. AstraZeneca said patients with a prescription will be able to order the drug and have it delivered to their homes. The company said a 90-day prescription will cost $18.33 a month whether or not patients have insurance, and shipping and handling will be free. Dutoprol will also be available in retail pharmacies.
AstraZeneca said the wholesale price of Dutoprol is similar to generic versions of Toprol XL.
Shares of AstraZeneca rose 30 cents to $44.72 in morning trading.
Posted: April 2012